- Abstracts may have been presented previously (within the past year) and cannot have published as a full manuscript in any journal.
- Abstracts must follow the Submission Guidelines below. IFCPC/ASCCP reserves the right to refuse review of an abstract, if it does not conform to all submission requirements.
- Case reports are rarely appropriate, unless they provide new insights and teach something important and true.
- Individuals whose abstracts are accepted must register for the meeting and pay the registration fee.
- Membership in IFCPC/ASCCP is not required for any presenting author or co-author of a submitted abstract.
- There are no restrictions on the number of abstracts submitted, but one person may only be designated as presenter on a maximum of two abstract submissions.
- Abstract Title must not be more than 120 characters, including spaces. Do not use uncommon abbreviations or acronyms in the title. Do not use Brand or Trade names in the Title. Capitalize the first letter and use lower case letters unless a specific word or words is/are ordinarily capitalized.
- Abstract must not be more than 250 words.
- Abstracts must be submitted in English, in a structured format.
- Each submission should include the following headings in bold:
-Objective - state concisely why the study was conducted
-Methods - indicate the type of study design, setting, location, patients, interventions or exposures, comparators, outcome measures, and statistics
-Results - the primary outcome of the study and statistical significance and major limitations; it is not satisfactory to state, “The results will be discussed.
-Conclusions - state the main conclusions of the study, the significance of the results and the implications of how the results may affect patient management, or our understanding of the condition.
- Authors may choose to upload supporting figures for review purposes; figures may not be in final publication. Authors may upload supporting tables, which may not be included in final publication.
Ethics of Research and Presentation
- Authors of reports of original research should present an accurate account of the work performed and an objective discussion of its importance. Fraudulent or knowingly inaccurate statements constitute unethical behavior and are unacceptable.
- If the work involves the use of animal subjects, the author should ensure that the work described was conducted in accordance with the position of the American Association for the Advancement for Science in requiring assurances of the responsible use of animals in research.
- If the work involves human subjects or data from human subjects in any way, the author must ensure that the work described was conducted in accordance with The Code of Ethics of the World Medical Association (Declaration of Helsinki) for experiments involving humans. A statement of IRB approval or waiver MUST be included In the Methods for research that involved human subject research in any way.
- The privacy rights of human subjects must always be observed. Patients must not be identified by name or initials. No other information, including clinical photos or family trees, from which a patient could be identified is permitted unless express written permission from the patient/family is provided at the time of manuscript submission.
- Appropriate consents, permissions and releases must be obtained when an author wishes to include case details or other personal information or images of patients and any other individuals. Unless written permission from the patient (or, where applicable, the next of kin) exists, the personal details of any patient included in any part of the report and in any supplementary materials (including all illustrations and videos) must be removed before submission. . A statement that the author has signed consent for publication MUST be included in the Methods. To respect patients and any other individual’s privacy, do not send signed consent forms to ASCCP. Retain the signed form(s) in the event they should be needed.
- A conflict of interest may exist when an author or the author's institution has a financial or other relationship with other people or organizations that may inappropriately influence the author's work.
- An Author’s disclosure for the presenting author must be declared at the time of abstract submission. If the presenting author is employed by a company as defined by the CMSS Code for Interactions with Companies (http://www.cmss.org/codeforinteractions.aspx), an alternate presenter who does not have a relevant employment relationship must be named if the abstract is accepted.
- All submissions will be peer reviewed anonymously by members of IFCPC/ASCCP, based on: scientific merit, originality, and relevancy to cervical pathology, colposcopy, and lower anourogenital tract diseases.
- Scientific Merit: Is the study design appropriate to the study aims? How strong are the research methods with respect to selection of participant (inclusion/exclusion) and procedures used to assess outcome measures? Is the analytic approach appropriate to the study goals? Do the study conclusions flow from the results? Are study limitations recognized? Is the research study presented in a clear and easily understandable manner?
- Originality: Is the study innovative? Does the project challenge and shift current research or clinical practice paradigms by utilizing novel theoretic concepts, approaches or methodologies, instrumentation or interventions? Are the results newsworthy?
- Relevancy: Does the project impact an important problem or a critical barrier to progress in the field of lower anourogenital tract disease? Does the project improve scientific knowledge, technical capability and/or clinical practice? Does the project change the concepts, methods technologies, treatments, services, or preventative interventions that drive the field of lower anourogenital tract disease? Are the goals of the science, the findings, and the interpretation readily accessible to the audience?
Notification of Receipt and Acceptance
- Receipt of abstract submissions will be acknowledged via email to the all authors.
- The presenting author will then be required to confirm that they will present at the IFCPC World Congress.
- Only a limited number of abstracts will be accepted for oral presentations. Submitters of these top-scoring abstracts will be invited to present their work from the podium of specific scientific sessions during the ASCCP Annual Meeting.
- Oral presentations are limited to *7-10 minutes followed by *3-5 minutes for questions-and-answers. Information about the length of each abstract presentation and the time of presentation will be determined and you will be informed after your abstract is accepted and the meeting schedule is finalized.
- Abstracts submitted may be accepted for poster presentation
- A poster should fit on a 4 foot (vertical) x 8 foot (horizontal) bulletin board.
- Authors are expected to be present during the dedicated poster session . Authors are encouraged to be present during breaks.
- Authors must set-up and remove their own poster.
- No video or stand-alone equipment should be placed next to the poster. Tablets/handouts can be used during dedicated poster presentation time to show supportng material.
- IFCPC/ASCCP recommends the following be included in posters:
- All of the same categories as the abstract (Objective, Methods, Results, Conclusion)
- Charts, graphs, pictures, etc.
- Study funding and conflict disclosure
- Statements of consent and approval